Free Trial

Mitsubishi UFJ Asset Management Co. Ltd. Has $3.41 Million Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA logo with Medical background

Mitsubishi UFJ Asset Management Co. Ltd. cut its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 45.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 97,887 shares of the medical instruments supplier's stock after selling 80,760 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.'s holdings in DENTSPLY SIRONA were worth $3,408,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in XRAY. Nuance Investments LLC lifted its stake in DENTSPLY SIRONA by 30.4% during the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier's stock worth $412,982,000 after purchasing an additional 2,702,457 shares during the last quarter. Forum Financial Management LP acquired a new position in DENTSPLY SIRONA during the fourth quarter worth approximately $200,000. Principal Financial Group Inc. increased its position in DENTSPLY SIRONA by 9.2% during the fourth quarter. Principal Financial Group Inc. now owns 1,394,740 shares of the medical instruments supplier's stock worth $49,639,000 after buying an additional 117,675 shares during the period. Dimensional Fund Advisors LP increased its position in DENTSPLY SIRONA by 10.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,122,355 shares of the medical instruments supplier's stock worth $75,535,000 after buying an additional 197,431 shares during the period. Finally, Teacher Retirement System of Texas increased its position in DENTSPLY SIRONA by 197.7% during the fourth quarter. Teacher Retirement System of Texas now owns 49,037 shares of the medical instruments supplier's stock worth $1,745,000 after buying an additional 32,566 shares during the period. Hedge funds and other institutional investors own 95.70% of the company's stock.


Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. Evercore ISI dropped their target price on DENTSPLY SIRONA from $40.00 to $35.00 and set an "outperform" rating on the stock in a report on Friday, May 3rd. Barrington Research dropped their price objective on DENTSPLY SIRONA from $41.00 to $38.00 and set an "outperform" rating on the stock in a report on Friday, May 3rd. The Goldman Sachs Group dropped their price objective on DENTSPLY SIRONA from $34.00 to $30.00 and set a "neutral" rating on the stock in a report on Monday, May 6th. Leerink Partnrs reaffirmed an "outperform" rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Finally, Needham & Company LLC dropped their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a "buy" rating on the stock in a report on Friday, May 3rd. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Moderate Buy" and an average price target of $35.22.

Read Our Latest Report on XRAY

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY traded up $0.08 on Tuesday, hitting $28.20. The company had a trading volume of 2,333,778 shares, compared to its average volume of 3,343,557. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA Inc. has a 52-week low of $26.27 and a 52-week high of $41.65. The business has a 50 day moving average of $30.86 and a 200 day moving average of $32.48. The company has a market cap of $5.86 billion, a PE ratio of -64.09, a PEG ratio of 1.24 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. During the same period in the prior year, the business earned $0.39 earnings per share. The business's revenue was down 2.6% on a year-over-year basis. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 2.03 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were given a $0.16 dividend. This is an increase from DENTSPLY SIRONA's previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a dividend yield of 2.27%. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA's dividend payout ratio is currently -145.45%.

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Stories

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should you invest $1,000 in DENTSPLY SIRONA right now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Will FOMC Push Stocks Higher? Here’s What to Expect
Unlock Growth: Understanding Dividend Yield
Palantir Stock Excluded from S&P 500: Still a Buy?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines